PMID: 21350334Feb 26, 2011Paper

How phosphorylation controls p53

Cell Cycle
Nicola J MacLaine, Ted R Hupp

Abstract

The tumor suppressor p53 is a transcription factor that integrates distinct environmental signals including DNA damage, metabolic stress, oncogene activation, hypoxia and virus infection into a common biological outcome that maintains normal cellular control and tissue integrity. p53 is regulated at the post-translational level by protein-protein interactions and covalent modifications, including phosphorylation at over twenty phosphor-acceptor sites. In this perspective we discuss the function of two evolutionarily conserved p53 phosphorylation motifs, located within the N-terminal transactivation and C-terminal regulatory domains, which have recently been shown to play a tumour suppressive role in stem cell niches. We also consider how mechanisms in addition to phosphorylation by stress-activated kinases can lead to the activation of p53 as a transcription factor, and we review the dual role of p53-activating kinases as tumor suppressors and oncoproteins. Finally, we discuss how changes in the specific activity of p53 can have profound effects not only on cancer development, but also on organism aging.

Citations

Apr 17, 2013·Proceedings of the National Academy of Sciences of the United States of America·Anni I NieminenJuha Klefström
May 19, 2012·Nucleic Acids Research·Leonardo G TrabucoRobert B Russell
Dec 6, 2012·Journal of Drug Delivery·Duncan Ayers, Alessandro Nasti
May 21, 2013·Cellular and Molecular Life Sciences : CMLS·Nikolina VlatkovićCarlos P Rubbi
Mar 15, 2012·EMBO Molecular Medicine·Chris T WilliamsonSusan P Lees-Miller
Dec 18, 2013·Cancer Metastasis Reviews·Kartik GuptaRajan Gogna
Jul 31, 2014·International Journal of Molecular Sciences·Xiaona JiBuyong Ma
May 26, 2012·Trends in Biochemical Sciences·Renée F Johnson, Neil D Perkins
Jan 10, 2012·Biochemical Pharmacology·Michelle Martinez-Rivera, Zahid H Siddik
Sep 21, 2011·Trends in Biochemical Sciences·Dong-Hyun Lee, Dipanjan Chowdhury
Sep 13, 2011·Cell Biology International·Giovannella BruscalupiSilvia Leoni
Sep 7, 2013·Bioorganic & Medicinal Chemistry Letters·Anne-Sophie HuartTed R Hupp
Jan 5, 2013·Cell Cycle·Lorenzo GalluzziGuido Kroemer
Nov 29, 2011·Current Opinion in Biotechnology·Abderahmane DerouicheIvan Mijakovic
Jan 20, 2012·International Neurourology Journal·Jayoung Kim, Michael R Freeman
Mar 10, 2017·Genes·Duncan Ayers, Jo Vandesompele
Oct 27, 2017·Nucleic Acids Research·Daniel D ScottMarlene Oeffinger
Sep 27, 2018·Journal of Molecular Cell Biology·Konstantinos KarakostisRobin Fåhraeus
Nov 12, 2017·Scientific Reports·Yinxing MaSvetlana Dokudovskaya
Jul 25, 2015·The Biochemical Journal·David W Meek
Nov 24, 2012·Oncotarget·Barak RotblatRichard A Knight
Dec 3, 2018·FASEB BioAdvances·Zhenping ChenThomas Albrecht
Sep 15, 2019·BMC Cancer·Konstantinos Karakostis, Robin Fåhraeus
Feb 2, 2021·Frontiers in Public Health·Mariafausta FischiettiEdoardo Alesse
Jul 19, 2021·Biochimica Et Biophysica Acta. Molecular Cell Research·Ulises Ahumada-CastroJ Cesar Cardenas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.